Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
Teva
Chubb
Covington
Merck
AstraZeneca
Chinese Patent Office
Accenture
Argus Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

Teligent Company Profile

« Back to Dashboard

What is the competitive landscape for TELIGENT, and what generic and branded alternatives to TELIGENT drugs are available?

TELIGENT has thirty-five approved drugs.



Summary for Teligent
US Patents:0
Tradenames:30
Ingredients:25
NDAs:35

Drugs and US Patents for Teligent

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent ZINACEF cefuroxime sodium INJECTABLE;INJECTION 050558-003 Oct 19, 1983 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent Pharma Inc DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074098-001 Feb 21, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent ZINACEF cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050558-002 Oct 19, 1983 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent Pharma Inc DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 208101-001 Feb 25, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent FORTAZ IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 050634-001 Apr 28, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent CEFOTAN cefotetan disodium INJECTABLE;INJECTION 050588-002 Dec 27, 1985 AP RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent Pharma Inc TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 208590-001 Mar 3, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent AQUAMEPHYTON phytonadione INJECTABLE;INJECTION 012223-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent CEFOTAN IN PLASTIC CONTAINER cefotetan disodium INJECTABLE;INJECTION 050694-002 Jul 30, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teligent Pharma Inc ERYTHROMYCIN erythromycin GEL;TOPICAL 208154-001 Jul 19, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Teligent

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC ranitidine hydrochloride INJECTABLE;INJECTION 019090-001 Oct 19, 1984 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Subscribe ➤ Subscribe
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
Julphar
Fish and Richardson
Argus Health
US Army
Dow
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot